Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 8/20 | 0.57 |
| ▸ | MC1R | Q01726 | 6/20 | 0.57 |
| ▸ | SSTR5 | P35346 | 5/20 | 0.47 |
| ▸ | SSTR4 | P31391 | 4/20 | 0.47 |
| ▸ | SSTR2 | P30874 | 3/20 | 0.47 |
| ▸ | IL23R | Q5VWK5 | 5/20 | 0.47 |
| ▸ | SSTR1 | P30872 | 3/20 | 0.46 |
| ▸ | SSTR3 | P32745 | 2/20 | 0.46 |
| ▸ | REN | P00797 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20362958 | 1.00 | MC4R (0.57) | MC4RMC1RSSTR5SSTR4SSTR2 | |
| SCHEMBL21392264 | 0.98 | MC4R (0.57) | MC4RMC1RSSTR5SSTR4SSTR2 | |
| SCHEMBL20206244 | 0.98 | MC4R (0.57) | MC4RMC1RSSTR5SSTR4SSTR2 | |
| SCHEMBL20206296 | 0.95 | MC1R (0.56) | MC4RMC1RIL23R | |
| SCHEMBL20206282 | 0.94 | MC4R (0.55) | MC4RMC1RIL23R | |
| SCHEMBL20363000 | 0.93 | MC4R (0.55) | MC4RMC1R | |
| SCHEMBL21392332 | 0.93 | MC4R (0.55) | MC4RMC1R | |
| SCHEMBL20362979 | 0.93 | MC4R (0.55) | MC4RMC1R | |
| SCHEMBL21392401 | 0.90 | MC4R (0.58) | MC4RMC1RIL23R | |
| SCHEMBL20206176 | 0.90 | MC1R (0.53) | MC4RMC1RIL23RREN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019183472-A1 | MELANOCORTIN RECEPTOR-SPECIFIC PEPTIDE FORMULATIONS AND METHODS FOR GASTROINTESTINAL TRACT-SPECIFIC DELIVERY | PALATIN TECHNOLOGIES, INC. (US) | 2019-09-26 | — | — | WO | disclosed |